Efficacy News and Research

RSS

New developments at Evosep to make clinical proteomics 100x more robust and 10x faster

J.P. Morgan Healthcare Conference – (January 8th, 2024) Evosep, a leading provider of sample preparation solutions for mass spectrometry-based proteomics, today announced a co-marketing agreement with Thermo Fisher Scientific, a world leader in serving science.

From Thermo Fisher Scientific Inc. 10 Jan 2024

Hearing aid usage linked to reduced mortality in adults with hearing impairments

Researchers determine the relationship between the use of hearing aids and mortality among adult United States residents with hearing impairment.

10 Jan 2024

"TimeMachine" algorithm revolutionizes circadian rhythm analysis with single blood sample

"TimeMachine," an algorithm developed by U.S. researchers, accurately predicts circadian phase from a single blood sample using gene expression, offering a novel, efficient approach to understanding circadian rhythms and their impact on health.

9 Jan 2024

New Omicron subvariants test vaccine limits, reveal unique infection challenges

Study reveals that the Omicron subvariants BA.2.86 and FLip show unique mutations and infectivity profiles, with BA.2.86 being highly infectious and resistant to most conventional antibodies, underscoring the need for updated vaccines.

9 Jan 2024

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children's Health researchers and published today in Cancer Research Communications, a journal of the American Association for Cancer Research.

9 Jan 2024

New imaging technique could transform diagnosis and treatment of steatotic liver disease

Steatotic liver disease (SLD), previously known as non-alcoholic fatty liver disease, which includes a range of conditions caused by fat build-up in the liver due to abnormal lipid metabolism, affects about 25% of the population worldwide, making it the most common liver disorder.

9 Jan 2024

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Children and adults with rare, deadly genetic diseases have fresh hope for curative therapies, thanks to a new collaboration between the Innovative Genomics Institute (IGI) and Danaher Corporation, a global life sciences and diagnostics innovator.

9 Jan 2024

Do e-health interventions for smoking cessation management work?

Efficacy of e-health interventions for smoking cessation management in smokers.

9 Jan 2024

Itchy skin? Possible atopic dermatitis? Lavender essential oil might be just what you're looking for

Researchers demonstrate that lavender essential oils, particularly linalyl acetate, effectively suppress atopic dermatitis without skin sensitization, offering a natural, accessible treatment option.

8 Jan 2024

Ginseng's hidden gems: Rare ginsenosides emerge as potent players in the future of medicine

Review in the Journal of Advanced Research summarizes the properties, applications, and production of rare ginsenosides (RGs), highlighting their potential in treating various diseases including cancer and cardiovascular ailments.

8 Jan 2024

Amino acid nanoparticles show promise for cancer treatment

Amino acids, such as tyrosine and tryptophan, are the fundamental building blocks that make up proteins.

8 Jan 2024

URI robot aims to accelerate motor skill restoration for stroke patients

Every year, about 800,000 new stroke cases are reported in the United States, often causing patients problems with both neurological and physical motor control. Disruptions in the mobility of the arms and hands, in particular, can have devastating impacts on stroke patients' quality of life.

8 Jan 2024

Does intermittent fasting improve your sports performance?

The effects of intermittent fasting on sports performance.

8 Jan 2024

Gut microbiota: the new frontier in Alzheimer’s disease research and therapy

The current evidence of the role of gut microbiota in Alzheimer’s disease (AD) pathogenesis.

8 Jan 2024

COMPANION study of digital therapy demonstrates reduced anxiety in patients with pulmonary fibrosis

Vicore Pharma Holding AB (publ), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), today announced positive results of the COMPANION study (NCT05330312), investigating the efficacy of AlmeeTM, a 9-week digital cognitive behavioral therapy (CBT) accessed through a smartphone or tablet.

8 Jan 2024

Digital CBT intervention reduces anxiety and improves quality of life for pulmonary fibrosis patients

Alex Therapeutics and Vicore Pharma today announced positive results of the COMPANION study, investigating the efficacy of Almee, a 9-week digital cognitive behavioral therapy (CBT) intervention accessed through a smartphone or tablet.

8 Jan 2024

Genetic keys to COVID-19 vaccine response unlocked

A genome-wide association study in the U.K. Biobank reveals genetic factors influencing IgG serostatus against SARS-CoV-2, highlighting the role of HLA class II genes in variable immune responses to COVID-19 vaccines.

7 Jan 2024

Fruit fly research solves human disease and fuels new cancer immunotherapy approach

Scientists have solved a cellular murder mystery nearly 25 years after the case went cold. Following a trail of evidence from fruit flies to mice to humans revealed that cannibalistic cells likely cause a rare human immunodeficiency.

5 Jan 2024

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

Scientists at St. Jude Children's Research Hospital are tackling Mycobacterium abscessus (Mab) antibiotic resistance.

5 Jan 2024

Breakthrough drug halts lung cancer and brain metastases

D'Or Institute for Research and Education (IDOR) played an important role in the phase III LIBRETTO-431 multicenter study, which evaluated the efficacy and safety of selpercatinib compared to control treatment, which consisted of platinum-based chemotherapy associated or not with pembrolizumab (immune checkpoint inhibitor) in non-small cell lung cancer (NSCLC).

5 Jan 2024

Efficacy News and Research

New developments at Evosep to make clinical proteomics 100x more robust and 10x faster

Hearing aid usage linked to reduced mortality in adults with hearing impairments

"TimeMachine" algorithm revolutionizes circadian rhythm analysis with single blood sample

New Omicron subvariants test vaccine limits, reveal unique infection challenges

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

New imaging technique could transform diagnosis and treatment of steatotic liver disease

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Do e-health interventions for smoking cessation management work?

Itchy skin? Possible atopic dermatitis? Lavender essential oil might be just what you're looking for

Ginseng's hidden gems: Rare ginsenosides emerge as potent players in the future of medicine

Amino acid nanoparticles show promise for cancer treatment

URI robot aims to accelerate motor skill restoration for stroke patients

Does intermittent fasting improve your sports performance?

Gut microbiota: the new frontier in Alzheimer’s disease research and therapy

COMPANION study of digital therapy demonstrates reduced anxiety in patients with pulmonary fibrosis

Digital CBT intervention reduces anxiety and improves quality of life for pulmonary fibrosis patients

Genetic keys to COVID-19 vaccine response unlocked

Fruit fly research solves human disease and fuels new cancer immunotherapy approach

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

Breakthrough drug halts lung cancer and brain metastases

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News